eMedicine Specialties > Otolaryngology and Facial Plastic Surgery > Middle Ear & Mastoid

Middle Ear, Otitis Media With Effusion: Differential Diagnoses & Workup

Author: Richard D Thrasher III, MD, Private Practice, McKinney, Texas
Contributor Information and Disclosures

Updated: Oct 26, 2009

Differential Diagnoses

Cleft Palate
Middle Ear, Acute Otitis Media, Surgical Treatment
Cystic Fibrosis
Middle Ear, Eustachian Tube, Inflammation/Infection
Eustachian Tube Function
Middle Ear, Tympanic Membrane, Infections
Malignant Tumors of the Nasal Cavity
Patulous Eustachian Tube
Malignant Tumors of the Temporal Bone
Middle Ear Function
Middle Ear, Acute Otitis Media, Medical Treatment

Other Problems to Be Considered

Benign nasopharyngeal masses
Nasopharyngeal carcinoma
Adenoid hypertrophy
Congenital defects affecting the eustachian tube and its egress
Ciliary dyskinesia
Immunoglobulin G (IgG) subclass deficiencies

Workup

Laboratory Studies

  • Traditionally, laboratory tests have rarely been used in the workup and diagnosis of otitis media with effusion (OME) unless another process is suspected. History taking and physical examination are sensitive and specific enough to facilitate accurate diagnosis and treatment of the disease. Obtaining cultures is not routine for OME but is discussed below with tympanocentesis in Procedures.
  • In rare cases, the erythrocyte sedimentation rate is determined to rule out bony destruction, or the CBC count is assessed to rule out active infection.

Imaging Studies

  • Plain radiography of the mastoid was once used effectively to screen for OME but is rarely used today given the sensitivity of history and physical examination in helping diagnose the disease.
  • CT scanning is extremely sensitive and not needed for diagnosis. However, CT is important in attempting to rule out potential complications of otitis media (eg, mastoiditis, sigmoid sinus thrombosis, erosion of bone with intracranial extension) or unusual lesions (eg, cholesteatoma). CT scanning is particularly important in unilateral OME when a nasopharyngeal or eustachian tube mass must be ruled out.
  • MRI is particularly useful in the workup for soft tissue masses that may be contributing to middle ear effusions because of its superior ability to delineate borders within soft tissues and help determine the extent of potential intracranial extension (often helpful in nasopharyngeal masses). In addition, MRI and its closely associated variants of magnetic resonance venography (MRV) and magnetic resonance arteriography (MRA) demonstrate complications such as thrombosis of the intracranial sinuses very well. However, when intracranial extension is present, either from invasion from the nasopharynx or the temporal bone, CT scanning helps define the bony anatomy more specifically and should be used in conjunction with MRI.

Other Tests

  • Tympanometry is perhaps the most useful of all tests in association with OME.
    • Tympanometry reveals a type B result in 43% of cases of OME and a type C result in 47% of cases. A type B tympanogram is an imperfect measure of OME with 81% sensitivity and 74% specificity versus myringotomy. More recent studies (after 2001) have shown a higher rate of sensitivity and specificity, both around 90%. This is likely because of improvements in the technology used.
    • This test is particularly useful in small children whose external auditory canals may be too small or too collapsible to permit adequate visualization of the tympanic membrane. However, in those younger than 7 months, tympanometry is unreliable because of excessive compliance of the external auditory canal. The 2003 Agency for Healthcare Research and Quality (AHRQ) evidence report states that tympanometry results in children older than 4 years are reliable.
    • This test is a cost-effective adjunct to physical examination. Several studies have compared tympanometry with pneumatic otoscopy in terms of accuracy in detecting MEE when compared with the criterion standard of myringotomy. Nearly all studies show that pneumatic otoscopy is slightly more sensitive, at around 93%, but they differ on specificity, showing rates from 50-88%. Many of the conclusions in these protocols stated that the greatest use for tympanometry is in aiding the clinician in ruling out MEE for what appears to be an immobile tympanic membrane on examination.
  • According to an updated clinical practice guideline on OME published in May 2004 by the joint efforts of the American Academy of Family Physicians, the American Academy of Otolaryngology-Head and Neck Surgery, and the American Academy of Pediatrics Subcommittee on Otitis Media with Effusion, audiology is a necessary component of the evaluation of certain patients with OME.3
    • The guidelines refer to recent randomized trials that have sought to determine if any long-term detrimental effects of OME are observed in children who have no hearing loss or risk factors for speech and language delay. When these children were followed for several years, no long-term detrimental effects were identified. Such results have shifted the paradigm for treatment so that chronic OME without hearing loss is no longer an absolute indication for the placement of tubes in children who are not at risk for language delays.
    • Studies examining hearing sensitivity in children with OME report that average pure tone hearing loss at 4 frequencies (500, 1000, 2000, and 4000 Hz) ranges from normal hearing to moderate hearing loss (0–55 dB). The 50th percentile is about 25 dB hearing level (HL), and approximately 20% of ears exceed 35 dB HL.
    • The committee stated that initial hearing testing can be done in a primary care setting for children aged 4 years or older but also stated that conventional audiometry with earphones is performed with a fail criterion of more than 20 dB HL at 1 or more frequencies (500, 1000, 2000, 4000 Hz) in either ear.
  • Language testing has also been advocated in the clinical practice guidelines for children with hearing loss (pure tone average greater than 20 dB HL on comprehensive audiometric evaluation). Testing for language delays is important because communication is integral to all aspects of human functioning. Young children with speech and language delays during the preschool years are at risk for continued communication problems and later delays in reading and writing.

Procedures

  • Tympanocentesis involves the aspiration of effusion from the middle ear.
    • This procedure can be performed as an office procedure, even in small children if necessary.
    • It can serve as both a therapeutic procedure and a diagnostic procedure.
    • The therapy consists of the removal of an MEE that can impair hearing or cause a sensation of aural fullness. Moreover, if performed in AOM, it may relieve a significant amount of pain.
    • The usefulness of tympanocentesis as a diagnostic procedure is greater with AOM that does not respond to antibiotics than in other conditions.
    • Tympanocentesis is useful to acquire specimens for culture in cases of AOM resistant to standard antibiotics and in immunocompromised hosts.
    • In RAOM, it may be used to obtain cultures and determine sensitivities.
  • The criterion standard for documentation of a MEE is myringotomy, which has the advantage of increased exposure and better suctioning when compared to tympanocentesis. The primary disadvantage is a larger incision with a greater, albeit small, chance of persistent perforation or otorrhea.

Histologic Findings

In AOM, temporal bone studies reveal vascular dilatation and hyperplasia, inflammation and metaplasia of the mucosa, gland formation, edema, and infiltration with a mononuclear cell population. These same findings may be present, to a lesser degree, in OME.

More on Middle Ear, Otitis Media With Effusion

Overview: Middle Ear, Otitis Media With Effusion
Differential Diagnoses & Workup: Middle Ear, Otitis Media With Effusion
Treatment & Medication: Middle Ear, Otitis Media With Effusion
Follow-up: Middle Ear, Otitis Media With Effusion
Multimedia: Middle Ear, Otitis Media With Effusion
References
Further Reading

References

  1. Crapko M, Kerschner JE, Syring M, Johnston N. Role of Extra-Esophageal Reflux in Chronic Otitis Media with Effusion. Laryngoscope. Jun 20 2007;[Medline].

  2. Yilmaz T, Koçan EG, Besler HT, Yilmaz G, Gürsel B. The role of oxidants and antioxidants in otitis media with effusion in children. Otolaryngol Head Neck Surg. Dec 2004;131(6):797-803. [Medline].

  3. [Guideline] Rosenfeld RM, Culpepper L, Doyle KJ, Grundfast KM, Hoberman A, Kenna MA. Clinical practice guideline: Otitis media with effusion. Otolaryngol Head Neck Surg. May 2004;130(5 Suppl):S95-118. [Medline].

  4. Kouwen HB, Dejonckere PH. Prevalence of OME Is Reduced in Young Children Using Chewing Gum. Ear Hear. Aug 2007;28(4):451-5. [Medline].

  5. [Best Evidence] Williamson I, Benge S, Barton S, Petrou M, Letley L, Fasey N, et al. A double-blind randomised placebo-controlled trial of topical intranasal corticosteroids in 4- to 11-year-old children with persistent bilateral otitis media with effusion in primary care. Health Technol Assess. Aug 2009;13(37):1-144. [Medline].

  6. Cantekin EI, Mandel EM, Bluestone CD, et al. Lack of efficacy of a decongestant-antihistamine combination for otitis media with effusion ("secretory" otitis media) in children. Results of a double-blind, randomized trial. N Engl J Med. Feb 10 1983;308(6):297-301. [Medline].

  7. Pichichero ME, Reiner SA, Brook I, et al. Controversies in the medical management of persistent and recurrent acute otitis media. Recommendations of a clinical advisory committee. Ann Otol Rhinol Laryngol Suppl. Aug 2000;183:1-12. [Medline].

  8. Bluestone CD, Beery QC, Andrus WS. Mechanics of the Eustachian tube as it influences susceptibility to and persistence of middle ear effusions in children. Ann Otol Rhinol Laryngol. Mar-Apr 1974;83:Suppl 11:27-34. [Medline].

  9. Boston M, McCook J, Burke B, Derkay C. Incidence of and risk factors for additional tympanostomy tube insertion in children. Arch Otolaryngol Head Neck Surg. Mar 2003;129(3):293-6. [Medline].

  10. Burton MJ, Rosenfeld RM. Grommets (ventilation tubes) for hearing loss associated with otitis media with effusion in children. Otolaryngol Head Neck Surg. Oct 2006;135(4):507-10. [Medline].

  11. Butler CC, van der Voort JH. Oral or topical nasal steroids for hearing loss associated with otitis media with effusion in children. Cochrane Database Syst Rev. 2002;4:CD001935.

  12. Gates GA. Acute otitis media and otitis media with effusion. In: Cummings CW, ed: Otolaryngology Head and Neck Surgery. Vol.5: Pediatric Otolaryngology. 3rd ed. St Louis, Mo: Mosby;1998: 461-477.

  13. Graham MD, Goldsmith MM. Infections of the ear. In: Lee KJ, ed: Essential Otolaryngology. 7th ed. New York, NY: McGraw-Hill;1999: 673-710.

  14. Kaleida PH. Evidence assessment of the accuracy of methods of diagnosing middle ear effusion in children with otitis media with effusion. J Pediatr. Jul 2004;145(1):138. [Medline].

  15. Kubba H, Pearson JP, Birchall JP. The aetiology of otitis media with effusion: a review. Clin Otolaryngol. Jun 2000;25(3):181-94. [Medline].

  16. Maw R, Bawden R. Spontaneous resolution of severe chronic glue ear in children and the effect of adenoidectomy, tonsillectomy, and insertion of ventilation tubes (grommets). BMJ. Mar 20 1993;306(6880):756-60. [Medline].

  17. Paradise JL. Managing otitis media: a time for change. Pediatrics. Oct 1995;96(4 Pt 1):712-5. [Medline].

  18. Paradise JL, Rockette HE, Colborn DK, et al. Otitis media in 2253 Pittsburgh-area infants: prevalence and risk factors during the first two years of life. Pediatrics. Mar 1997;99(3):318-33. [Medline].

  19. Pichichero ME, Poole MD. Assessing diagnostic accuracy and tympanocentesis skills in the management of otitis media. Arch Pediatr Adolesc Med. Oct 2001;155(10):1137-42. [Medline].

  20. [Guideline] Rosenfeld RM, Culpepper L, Doyle KJ. Clinical practice guideline: Otitis media with effusion. Otolaryngol Head Neck Surg. May 2004;130 (5 Suppl):S95-118. [Medline][Full Text].

  21. Rosenfeld RM, Kay D. Natural history of untreated otitis media. Laryngoscope. Oct 2003;113(10):1645-57. [Medline].

  22. Tracy JM, Demain JG, Hoffman KM, Goetz DW. Intranasal beclomethasone as an adjunct to treatment of chronic middle ear effusion. Ann Allergy Asthma Immunol. Feb 1998;80(2):198-206. [Medline].

  23. Williams RL, Chalmers TC, Stange KC, et al. Use of antibiotics in preventing recurrent acute otitis media and in treating otitis media with effusion. A meta-analytic attempt to resolve the brouhaha. JAMA. Sep 15 1993;270(11):1344-51. [Medline].

  24. Williamson I. Otitis media with effusion. Clin Evid. Jun 2002;469-76. [Medline].

  25. Williamson IG, Dunleavey J, Bain J, Robinson D. The natural history of otitis media with effusion--a three-year study of the incidence and prevalence of abnormal tympanograms in four South West Hampshire infant and first schools. J Laryngol Otol. Nov 1994;108(11):930-4. [Medline].

Further Reading

Clinical guidelines

Cincinnati Children's Hospital Medical Center. Evidence based clinical practice guideline for medical management of acute otitis media in children 2 months to 13 years of age. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2004 Oct. 16 p.

University of Michigan Health System (UMHS). Otitis media. Ann Arbor (MI): University of Michigan Health System (UMHS); 2007 July. 12 p.

Keywords

otitis media with effusion, OME, middle ear, effusion, mucoid otitis media, serous otitis media, glue ear, chronic otitis media with effusion, COME, secretory otitis media, acute otitis media, AOM, recurrent acute otitis media, RAOM, inflammation of the middle ear, middle ear effusion, MEE, ear infection, ear ache, hearing loss, aural fullness

Contributor Information and Disclosures

Author

Richard D Thrasher III, MD, Private Practice, McKinney, Texas
Richard D Thrasher III, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American Medical Association, and American Rhinologic Society
Disclosure: Nothing to disclose.

Medical Editor

Douglas D Backous, MD, Director of Listen for Life Center, Department of Otolaryngology-Head and Neck Surgery, Virginia Mason Medical Center
Douglas D Backous, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American Auditory Society, American College of Surgeons, American Laryngological Rhinological and Otological Society, American Medical Association, Association for Research in Otolaryngology, North American Skull Base Society, Society for Neuroscience, and Washington State Medical Association
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Gregory C Allen, MD, Assistant Professor, Department of Otolaryngology-Head and Neck Surgery, University of Colorado School of Medicine
Gregory C Allen, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American Academy of Pediatrics, American Cleft Palate/Craniofacial Association, American College of Surgeons, American Laryngological Rhinological and Otological Society, American Medical Association, Christian Medical & Dental Society, and Colorado Medical Society
Disclosure: Nothing to disclose.

CME Editor

Christopher L Slack, MD, Otolaryngology-Facial Plastic Surgery, Private Practice, Associated Coastal ENT; Medical Director, Treasure Coast Sleep Disorders
Christopher L Slack, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Medical Association
Disclosure: Nothing to disclose.

Chief Editor

Arlen D Meyers, MD, MBA, Professor, Department of Otolaryngology-Head and Neck Surgery, University of Colorado School of Medicine
Arlen D Meyers, MD, MBA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Head and Neck Society
Disclosure: Covidien Corp Consulting fee Consulting; US Tobacco Corporation unstricted gift unknown; Axis Three Corporation Ownership interest Consulting; Omni Biosciences Ownership interest Consulting; Sentegra Ownership interest Board membership; Syndicom Ownership interest Consulting; Oxlo  Consulting; Medvoy Ownership interest Management position

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.